PAVmed Inc
Price
FilingsNewest: 8-K, Material agreementSep 9 →InsidersNo open-market buys or sales.→HoldersTwo Seas Capital 7.4%First Manhattan 5.3%Vanguard 1.0%→Financing →PeersClosest companies: LUCD, VJET, NVNO→
From the filings
Figures
- Revenue
- $112,000last 12 months
- Net income
- −$12.1Mlast 12 months
- Operating cash flow
- −$6.2Mlast 12 months
- Cash and equivalents
- $3.8Mat the last balance sheet
- Shares outstanding
- 6.3M shareson issue